Benzydamine inhibits osteoclast differentiation and bone resorption via down-regulation of interleukin-1β expression

Bone diseases such as osteoporosis and periodontitis are induced by excessive osteoclastic activity, which is closely associated with inflammation. Benzydamine (BA) has been used as a cytokine-suppressive or non-steroidal anti-inflammatory drug that inhibits the production of pro-inflammatory cytoki...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Han Saem Son, Jiae Lee, Hye In Lee, Narae Kim, You-Jin Jo, Gong-Rak Lee, Seong-Eun Hong, Minjeong Kwon, Nam Young Kim, Hyun Jin Kim, Jin Ha Park, Soo Young Lee, Woojin Jeong
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2020-03-01
coleção:	Acta Pharmaceutica Sinica B
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2211383519303132
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!